Daniel M. Moreira

Daniel M. Moreira

University of Illinois at Chicago

H-index: 42

North America-United States

About Daniel M. Moreira

Daniel M. Moreira, With an exceptional h-index of 42 and a recent h-index of 29 (since 2020), a distinguished researcher at University of Illinois at Chicago, specializes in the field of Urologic Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

PD29-01 DOES INSULIN RESISTANCE PREDICT AGGRESSIVE PROSTATE CANCER? RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER (REDUCE) TRIAL

PD03-05 DOES INSULIN RESISTANCE CREATE A BIGGER PROSTATE? RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial.

PD02-06 SERUM TESTOSTERONE AND DIHYDROTESTOSTERONE AND INCIDENCE AND PROGRESSION OF LOWER URINARY TRACT SYMPTOMS IN REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS TRIAL

Serum testosterone and dihydrotestosterone and incidence and progression of lower urinary tract symptoms: results from the REDUCE study

Perioperative outcomes in male patients undergoing cystectomy, radical colorectal procedure or total pelvic exenteration

Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial

Smoking and lower urinary tract symptoms in Reduction by Dutasteride of Prostate Cancer Events Trial

Daniel M. Moreira Information

University

Position

___

Citations(all)

6505

Citations(since 2020)

3809

Cited By

4180

hIndex(all)

42

hIndex(since 2020)

29

i10Index(all)

121

i10Index(since 2020)

89

Email

University Profile Page

University of Illinois at Chicago

Google Scholar

View Google Scholar Profile

Daniel M. Moreira Skills & Research Interests

Urologic Oncology

Top articles of Daniel M. Moreira

Title

Journal

Author(s)

Publication Date

PD29-01 DOES INSULIN RESISTANCE PREDICT AGGRESSIVE PROSTATE CANCER? RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER (REDUCE) TRIAL

The Journal of Urology

Renning Zheng

James P Daniels

Daniel Moreira

Stephen J Freedland

2024/5

PD03-05 DOES INSULIN RESISTANCE CREATE A BIGGER PROSTATE? RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

The Journal of Urology

James P Daniels

James Mirocha

Renning Zheng

Daniel M Moreira

Stephen J Freedland

2024/5

Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial.

Hari Thambiah Vigneswaran

Martin Eklund

Andrea Discacciati

Tobias Nordström

Rebecca A Hubbard

...

2024/2/1

PD02-06 SERUM TESTOSTERONE AND DIHYDROTESTOSTERONE AND INCIDENCE AND PROGRESSION OF LOWER URINARY TRACT SYMPTOMS IN REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS TRIAL

The Journal of Urology

James Daniels

James Mirocha

Daniel Moreira

Gerald Andriole

Stephen Freedland

2023/4

Serum testosterone and dihydrotestosterone and incidence and progression of lower urinary tract symptoms: results from the REDUCE study

Journal of Urology

James P Daniels

James Mirocha

Michie Adjei

Daniel Moreira

Stephen J Freedland

2023/11/27

Perioperative outcomes in male patients undergoing cystectomy, radical colorectal procedure or total pelvic exenteration

Translational Andrology and Urology

Ushasi Naha

Artyom Khurshudyan

Hari T Vigneswaran

Mahmoud Mima

Michael R Abern

...

2023/11/11

Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial

Cancer medicine

Samuel Carbunaru

Zequn Sun

Cordero McCall

Bernice Ofori

Norma Marshall

...

2023/10

Smoking and lower urinary tract symptoms in Reduction by Dutasteride of Prostate Cancer Events Trial

The Prostate

Jordan J Kramer

Lin Gu

Daniel Moreira

Gerald Andriole

Stephen J Freedland

...

2023/7

Adverse events and androgen receptor signaling inhibitors in the treatment of prostate cancer: a systematic review and multivariate network meta-analysis

Brent Cao

Melissa Kim

Natalie M Reizine

Daniel M Moreira

2023/6/1

Adverse events associated with androgen receptor signaling inhibitors in the treatment of prostate cancer: A systematic review and network meta-analysis.

Brent Cao

Melissa Kim

Natalie Marie Reizine

Daniel Moreira

2022/10/1

The impact of smoking on sexual function

BJU international

Mahmoud Mima

Jason B Huang

Gerald L Andriole

Stephen J Freedland

Samuel J Ohlander

...

2022/8

Prostate cancer disparities in Hispanics using the national cancer database

Urology

Matthew Del Pino

Michael R Abern

Daniel M Moreira

2022/7/1

Statin Use and Lower Urinary Tract Symptoms Incidence and Progression in Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial

The Journal of Urology

Jordan J Kramer

Lin Gu

Daniel Moreira

Gerald Andriole

Ilona Csizmadi

...

2022/2

Morbidity and mortality of total pelvic exenteration for malignancy in the US

Annals of Surgical Oncology

Hari T Vigneswaran

Logan S Schwarzman

Ikenna C Madueke

Shannon MacLaughlan David

Johan Nordenstam

...

2021/5

Association between environmental quality and prostate cancer stage at diagnosis

Prostate Cancer and Prostatic Diseases

Hari T Vigneswaran

Jyotsna S Jagai

David T Greenwald

Achal P Patel

Megh Kumar

...

2021/12

Chronic baseline prostate inflammation is associated with lower tumor grade in men with prostate cancer on repeat biopsy: results from the REDUCE study

The Journal of urology

Ushasi Naha

J Curtis Nickel

Gerald L Andriole

Stephen J Freedland

Daniel M Moreira

2021/3

Smoking Is Associated With Basal Cell Hyperplasia on Prostate Biopsy Specimens

American journal of clinical pathology

Daniel Melecchi Freitas

Gerald L Andriole Jr

Stephen J Freedland

Brasil S Neto

Daniel M Moreira

2021/11/1

Partial validation of the sleep health construct in the medical outcomes study sleep questionnaire

Journal of clinical psychology in medical settings

Donald L Bliwise

Lauren E Howard

Daniel M Moreira

Gerald L Andriole

Martin L Hopp

...

2021/3

MP28-08 SMOKING AND INCIDENCE AND PROGRESSION OF LOWER URINARY TRACT SYMPTOMS (LUTS) IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

Journal of Urology

Jordan J Kramer

Illona Csizmadi

Lin Gu

Daniel Moreira

Gerald Andriole

...

2021/9/1

Dutasteride improves nocturia but does not lead to better sleep: results from the REDUCE clinical trial

The Journal of urology

Paige K Kuhlmann

Sean C Fischer

Lauren E Howard

Daniel M Moreira

Gerald L Andriole

...

2021/6

See List of Professors in Daniel M. Moreira University(University of Illinois at Chicago)

Co-Authors

H-index: 196
Paolo Boffetta

Paolo Boffetta

Stony Brook University

H-index: 87
Matthew Cooperberg

Matthew Cooperberg

University of California, San Francisco

H-index: 83
Christopher J Kane

Christopher J Kane

University of California, San Diego

H-index: 38
Zham Okhunov, MD

Zham Okhunov, MD

University of California, Irvine

H-index: 30
Leah Gerber Davis

Leah Gerber Davis

Duke University

H-index: 28
Michael Abern

Michael Abern

University of Illinois at Chicago

academic-engine